We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
10 Year Est. Return
AUM
$13.7B
AUM Growth
+$1.01B
Cap. Flow
+$589M
Cap. Flow %
4.3%
Top 10 Hldgs %
11.63%
Holding
1,581
New
640
Increased
361
Reduced
263
Closed
311

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.4M
2
PFE icon
Pfizer
PFE
+$82.7M
3
MCD icon
McDonald's
MCD
+$65.4M
4
KDP icon
Keurig Dr Pepper
KDP
+$64.6M
5
ULTA icon
Ulta Beauty
ULTA
+$63.9M

Sector Composition

Rank Sector Weight
1 Healthcare 20.96%
2 Technology 16.17%
3 Consumer Discretionary 15.54%
4 Industrials 10.23%
5 Financials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZTA icon
1026
Azenta
AZTA
$1.42B
$699K 0.01%
+31,767
New +$805K
SJR
1027
DELISTED
Shaw Communications Inc.
SJR
$698K 0.01%
31,715
+7,639
+32% +$164K
CDE icon
1028
Coeur Mining
CDE
$18B
$689K 0.01%
+76,523
New +$695K
AIT icon
1029
Applied Industrial Technologies
AIT
$13.3B
$687K 0.01%
+11,637
New +$713K
TAST
1030
DELISTED
Carrols Restaurant Group, Inc.
TAST
$686K 0.01%
+57,146
New +$747K
XLRN
1031
DELISTED
Acceleron Pharma
XLRN
$685K 0.01%
22,833
-44,730
-66% -$1.3M
ATHN
1032
DELISTED
Athenahealth, Inc.
ATHN
$682K 0.01%
4,834
-21,093
-81% -$2.63M
CMS icon
1033
CMS Energy
CMS
$22.3B
$677K ﹤0.01%
14,707
-275,053
-95% -$12.7M
B
1034
Barrick Mining
B
$68.3B
$675K ﹤0.01%
+42,155
New +$721K
ANIK icon
1035
Anika Therapeutics
ANIK
$259M
$674K ﹤0.01%
+13,756
New +$633K
FINL
1036
DELISTED
Finish Line
FINL
$673K ﹤0.01%
+48,087
New +$698K
CUBE icon
1037
CubeSmart
CUBE
$9.47B
$672K ﹤0.01%
+28,005
New +$710K
FOSL icon
1038
Fossil Group
FOSL
$358M
$671K ﹤0.01%
67,089
+52,626
+364% +$712K
CSV icon
1039
Carriage Services
CSV
$651M
$667K ﹤0.01%
+24,706
New +$664K
TECD
1040
DELISTED
Tech Data Corp
TECD
$664K ﹤0.01%
+6,579
New +$633K
DLB icon
1041
Dolby
DLB
$5.67B
$657K ﹤0.01%
+13,416
New +$684K
DLX icon
1042
Deluxe
DLX
$1.22B
$655K ﹤0.01%
+9,487
New +$661K
ENS icon
1043
EnerSys
ENS
$7.05B
$655K ﹤0.01%
+9,097
New +$716K
CHUY
1044
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$642K ﹤0.01%
+27,923
New +$770K
QHC
1045
DELISTED
Quorum Health Corporation
QHC
$637K ﹤0.01%
+159,142
New +$653K
EGL
1046
DELISTED
Engility Holdings, Inc.
EGL
$632K ﹤0.01%
+22,560
New +$629K
CATM
1047
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$631K ﹤0.01%
+19,120
New +$716K
GWR
1048
DELISTED
Genesee & Wyoming Inc.
GWR
$628K ﹤0.01%
9,236
-134,488
-94% -$8.88M
TDAY
1049
USA Today Co
TDAY
$1.28B
$625K ﹤0.01%
+48,053
New +$641K
DCOM
1050
DELISTED
Dime Community Bancshares
DCOM
$623K ﹤0.01%
+31,129
New +$620K

Similar funds

Marshall Wace North America's Q2 2017 Portfolio in Review

As of Q2 2017, Marshall Wace North America held 1,581 positions worth $13.7B, up 8% from $12.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace North America deployed $589M of net new capital in Q2 2017, opening 640 new positions and adding to 361 existing holdings. Its largest new stake was Ulta Beauty: 218,927 shares worth $62.8M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was T-Mobile US, an estimated $225M trimmed.

  • Marshall Wace North America's largest Q2 2017 buy was Ulta Beauty: 218,927 shares worth $62.8M.
  • Marshall Wace North America added most to Alphabet (Google) Class A in Q2 2017, an estimated $90.4M increase.
  • Marshall Wace North America's biggest Q2 2017 reduction was T-Mobile US, cutting an estimated $225M.
  • Marshall Wace North America fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $120M.
  • Marshall Wace North America's ten largest holdings make up 12% of its $13.7B portfolio in Q2 2017.
  • Marshall Wace North America opened 640 new positions and closed 311 in Q2 2017.
  • Marshall Wace North America's portfolio value rose 8% quarter-over-quarter to $13.7B.

Based on Marshall Wace North America's 13F filing for Q2 2017, filed 4 Aug 2017.